Volume 31, Number 4—April 2025
Research
Neutralizing Antibodies against California Serogroup Orthobunyaviruses in Human Serum Samples, Montana, USA
Table 1
Positivity of samples tested in a study of neutralizing antibodies against California serogroup orthobunyaviruses in human serum samples, Montana, USA*
Characteristics | Total | Total – SW2 | % JCV-positive, n = 159 |
% Dual positive samples, n = 87 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Hospital region |
||||||||||
NW | SW1 | SW2 | NC | SC | E | |||||
Total samples |
190 |
103 |
212 |
201 |
100 |
100 |
906 |
694 |
NA |
NA |
JCV-positive |
55 (29) |
21 (20) |
31 (15) |
35 (17) |
17 (17) |
31 (31) |
190 (21) |
159 (23) |
100 |
NA |
Cross-reactivity | ||||||||||
Single high titer | ||||||||||
JCV | 18 | 6 | ND | 7 | 4 | 3 | NA | 38 (5.4) | 23.8 | NA |
SSHV | ND | ND | ND | ND | ND | ND | NA | 0 | 0 | NA |
LACV | ND | ND | ND | ND | ND | 10 | NA | 10 (1) | 6.2 | NA |
CEV | 4 | 1 | ND | 5 | 4 | 4 | NA | 18 (3) | 11.3 | NA |
TVTV | 1 | 2 | ND | 1 | 2 | NA | 6 (1) | 3.8 | NA | |
CVV | ND | ND | ND | ND | ND | ND | NA | 0 | 0 | NA |
Dual or triple high titers† | ||||||||||
Total no. | 32 | 12 | ND | 22 | 9 | 12 | NA | 87 (12) | 54.7 | 100 |
JCV + SSHV | ND | ND | ND | ND | ND | ND | NA | 0 | 0 | 0 |
JCV + LACV | 1 | ND | ND | 1 | ND | 1 | NA | 3 (0.4) | 1.9 | 3.4 |
JCV + CEV | 13 | 2 | ND | 8 | 6 | 4 | NA | 33 (4.8) | 20.7 | 37.9 |
JCV + TVTV | 7 | ND | ND | 7 | ND | ND | NA | 14 (2) | 8.8 | 16.1 |
SSHV + LACV | ND | ND | ND | ND | ND | ND | NA | 0 | 0 | 0 |
SSHV + CEV | 1 | ND | ND | 1 | 1 | ND | NA | 3 (0.4) | 1.9 | 1 |
LACV + CEV | 1 | ND | ND | ND | 1 | ND | NA | 2 (0.2) | 1.2 | 2.3 |
LACV + TVTV | ND | ND | ND | ND | ND | 2 | NA | 2 (0.2) | 1.2 | 2.3 |
CEV + TVTV | ND | ND | ND | ND | ND | ND | NA | 0 | 0 | 0 |
Triple | 9 | 10 | ND | 5 | 1 | 5 | NA | 30 (4.3) | 18.9 | 34.5 |
*Values are no. (%) except as indicated. CEV, California encephalitis virus; E, east; JCV, Jamestown Canyon virus; LACV, La Crosse virus; NA, not applicable; NC, north central; ND, not detected; NW, northwest; SC, south central; SSHV, snowshoe hare virus; SW, south-west; TVTV, Trivittatus virus.
1These first authors contributed equally to this article.
2Current affiliation: Department of Microbiology and Cell Biology, Montana State University, Bozeman, Montana, USA
Page created: February 08, 2025
Page updated: March 24, 2025
Page reviewed: March 24, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.